跳至主要内容
临床试验/CTRI/2024/07/069830
CTRI/2024/07/069830招募中3 期

Randomized controlled trial to evaluate the efficacy of Laghumanjisthadi kashaya and Mahatrinaka Taila in the management of Vicharchika W.S.R to Eczema

National Institute of Ayurveda, Deemed to be university, Jaipur1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月1日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
changes in EASI score from the baseline value after Four weeks

研究概览

简要总结

The skin is the largest organ of the human body which is related to visual clinical speciality. skin is envelop of internal structure, which protects us against mechanical, chemical and biological hazards.  Now a  days, a Gradual increase in the prevalence of Vicharchika (Eczema) has been observed at general OPD level. The whole world is turning towards Ayurveda. Ayurveda has a lot to offer in this regard. so as vaidhya it’s our duty to help society as much as we can do. So that’s why vicharchika is chosen as a topic for research. Vicharchika has been correlated with eczema which has tendency of exacerbation and follows a chronic relapsing & remitting course.  So it is the need of the hour to find out safe and cost effective medicine for Vicharchika on a long term and here comes the role of Ayurveda. Therefore, keeping all these facts in mind, it has been decided to conduct a clinical study entitled as“A RANDOMISED CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF LAGHUMANJISHTHADI KASHAYA AND MAHA TRINAKA TAILA IN THE MANAGEMENT OF VICHARCHIKA W.S.R. TO ECZEMA.

Aim:  To evaluate the efficacy of “Laghumanjishthadi Kashaya and Mahatrinaka Taila in the management of Vicharchika w.s.r. to Eczema.

Objectives :

Primary objective: To study the effect of Laghumanjisthadi Kashaya and Mahatrinaka Taila on EASI score.

Secondary objectives: To study the effect of Laghumanjisthadi Kashaya and Mahatrinaka Taila in the Erythema, Dryness, Itching, Scaling, Discoloration, Oozing.

Null hypothesis[H0] : There is no difference in treatment outcome between the trial drug (“Laghumanjishthadi Kashaya and Mahatrinaka Tail”) and conventional first line drugs (Glycerin ointment & Tab Fexofenadine) in the management of Vicharchika w.s.r. to Eczema.

Alternative hypothesis[H1] :  There is difference in treatment outcome between trial drug( “Laghumanjishthadi Kashaya and Mahatrinaka Taila”) and conventional first line drugs (Glycerin ointment & tab Fexofenadine) in the management of Vicharchika w.s.r. to Eczema.

Study design : Phase of clinical study : Phase 2; Study type : Intervention, Single Centre, Randomized, Open label, Timing : Prospective,  Number of groups :two; Number of patients : 60 , Duration of study : 28 days( 4 weeks) .

The information gathered through observation will be used for statistical analysis in terms of Mean, Standard Deviation and Standard error (SE). For intra-group assessment, Wilcoxon matched – pairs signed Ranks test will be used for non – parametric data & for parametric data Paired ‘t-test’ will be used and results will be calculated. For inter-group comparisons, for the Non parametric variables Mann-Whitney Test will be used while for Parametric variables Unpaired ‘t’ Test will be used for statically analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients age between 18-60 years, irrespective of sex.
  • Patients having clinical signs and symptoms of Eczema like pruritis, oozing, Eruptions, Discoloration, Dryness, Thickening of skin.
  • Patients having chronicity less than 5 years.

排除标准

  • Patients below the age of 18 years and above 60 years.
  • 2.Patients with Steroid and cytotoxic treatment greater than 5 years 3.Patient having concomitant illness like HIV, Malignancy.
  • 4.Pregnant or lactating women.
  • 5.Patient participated in any clinical trial for last 6 months.

结局指标

主要结局

changes in EASI score from the baseline value after Four weeks

时间窗: At baseline and after 4 weeks

次要结局

  • changes in following parameters-(• Change in intensity of itching, roughness of skin, oozing from lesion site , skin)

研究者

发起方
National Institute of Ayurveda, Deemed to be university, Jaipur
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Neha Agrawal

National Institute of Ayurveda, Deemed to be university, Jaipur

研究点 (1)

Loading locations...

相似试验